Clinical Trial Update: Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing raltegravir to efavirenz in ART-naive HIV-1 patients on rifampin for active tuberculosis; completed status ongoing results not provided …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Raltegravir (raltegravir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 Infection, Tuberculosis | Phase 3 | Status: COMPLETED